TC
Thomas Catinazzo
Chief Financial Officer

Thomas Catinazzo insider trades: Relay Therapeutics (RLAY) stock sales

Chief Financial Officer, Relay Therapeutics Last trade Oct 28, 2026 53 Form 4 filings
$4.5M
Sold, last 12 months
9 sales
$0
Bought, last 12 months
0 buys
46
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

46 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 28, 2026RLAY↓ Sell$27K
Oct 6, 2026RLAY↓ Sell$329K
Jul 28, 2026RLAY↓ Sell$27K
Jul 6, 2026RLAY↓ Sell$331K
Jun 22, 2026RLAY↓ Sell$3.2M
May 14, 2026RLAY↓ Sell$228K
Apr 28, 2026RLAY↓ Sell$14K
Apr 9, 2026RLAY↓ Sell$257K
Jan 28, 2026RLAY↓ Sell$120K
Oct 28, 2025RLAY↓ Sell$158K
Jul 29, 2025RLAY↓ Sell$74K
Apr 30, 2025RLAY↓ Sell$59K
Mar 27, 2025RLAY↓ Sell$14K
Jan 30, 2025RLAY↓ Sell$268K
Dec 27, 2024RLAY↓ Sell$21K
Oct 29, 2024RLAY↓ Sell$55K
Sep 27, 2024RLAY↓ Sell$48K
Jul 29, 2024RLAY↓ Sell$92K
Jun 27, 2024RLAY↓ Sell$58K
Apr 29, 2024RLAY↓ Sell$11K
Mar 27, 2024RLAY↓ Sell$3K
Jan 29, 2024RLAY↓ Sell$19K
Dec 27, 2023RLAY↓ Sell$3K
Oct 30, 2023RLAY↓ Sell$10K
Sep 27, 2023RLAY↓ Sell$2K
Jul 28, 2023RLAY↓ Sell$20K
Jun 27, 2023RLAY↓ Sell$4K
Apr 28, 2023RLAY↓ Sell$10K
Mar 27, 2023RLAY↓ Sell$5K
Jan 30, 2023RLAY↓ Sell$19K
Dec 27, 2022RLAY↓ Sell$6K
Oct 28, 2022RLAY↓ Sell$24K
Sep 27, 2022RLAY↓ Sell$10K
Sep 8, 2022RLAY↓ Sell$788K
Jul 28, 2022RLAY↓ Sell$16K
Jun 27, 2022RLAY↓ Sell$6K
Apr 28, 2022RLAY↓ Sell$19K
Mar 29, 2022RLAY↓ Sell$8K
Mar 24, 2022RLAY↓ Sell$399K
Dec 27, 2021RLAY↓ Sell$10K
Nov 15, 2021RLAY↓ Sell$797K
Sep 27, 2021RLAY↓ Sell$11K
Sep 13, 2021RLAY↓ Sell$788K
Jun 28, 2021RLAY↓ Sell$10K
Jun 7, 2021RLAY↓ Sell$788K
Mar 30, 2021RLAY↓ Sell$788K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RLAY insiders

Open-market trades in the last 12 months

About Thomas Catinazzo's insider trades

Thomas Catinazzo is Chief Financial Officer at Relay Therapeutics (RLAY). Since Mar 30, 2021, Thomas has reported no open-market purchases and 46 sales worth $9.9M on SEC Form 4. In the last 12 months: 9 sales ($4.5M).

Their filings also include option exercises (8 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.